FdaApplication
ANDA 075520
Identifiers
- fda_app_no: ANDA075520
Properties
| Property | Value |
|---|---|
| applicant_name | TARO PHARMACEUTICAL INDUSTRIES LTD |
| application_type | ANDA |
| approval_date | 2000-05-08 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE;ORAL |
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE;ORAL |
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 50MG BASE | CAPSULE;ORAL |
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE;ORAL |
4 products